lurbinectedin
Showing 1 - 14 of 14
Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)
Not yet recruiting
- Ovarian Cancer
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,
Recruiting
- Advanced Soft-tissue Sarcoma
- +3 more
- Lurbinectedin
- Doxorubicin
-
Boston, Massachusetts
- +1 more
Feb 14, 2022
Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)
Recruiting
- Lung Cancer
- Small-cell Lung Cancer
- Trilaciclib
- Lurbinectedin
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Nov 9, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
- Lurbinectedin
- Berzosertib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 30, 2022
Advanced Solid Tumor, Hepatic Impairment Trial in Málaga, Barcelona, Madrid (Lurbinectedin)
Recruiting
- Advanced Solid Tumor
- Hepatic Impairment
- Lurbinectedin
-
Málaga, Andalucía, Spain
- +5 more
Oct 19, 2021
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta (Lurbinectedin, Palliative Radiation
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Lurbinectedin
- Palliative Radiation Therapy
-
Atlanta, Georgia
- +2 more
Apr 12, 2022
Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan
Withdrawn
- Metastatic Ewing Sarcoma
- Recurrent Ewing Sarcoma
- Fine-Needle Aspiration
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small
Recruiting
- Platinum-Resistant Lung Small Cell Carcinoma
- +3 more
- Durvalumab
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 11, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
- Lurbinectedin
- Irinotecan
-
Boston, Massachusetts
- +3 more
Nov 26, 2021
Malignant Pleural Mesothelioma, Advanced Trial in Italy, Switzerland (Lurbinectedin)
Completed
- Malignant Pleural Mesothelioma, Advanced
- Lurbinectedin
-
Alessandria, Italy
- +7 more
Jul 13, 2021
Small Cell Lung Cancer Trial (Lurbinectedin)
Approved for marketing
- Small Cell Lung Cancer
- Lurbinectedin
- (no location specified)
Jun 17, 2020
Relapsed Small Cell Lung Cancer Trial in Worldwide (Irinotecan, Lurbinectedin, Topotecan)
Recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan
- +2 more
-
Joliet, Illinois
- +94 more
Aug 12, 2022